SEC Form 4 · accession 0001209191-18-036984
ANAPTYSBIO, INC · ANAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hamza Suria
Officer — President, CEO · Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 11, 2018 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001370053
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2018 | M | 22,428 | $2.59 | A | 27,426 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.59 | Jun 8, 2018 | M | 22,428 | D | — | Dec 8, 2018 | Common Stock | 22,428 | 0 | D |
Explanation of responses
- F1The stock option is fully vested and immediately exercisable.